Molecular target size of NMDA antagonist binding sites.
D000818:Animals; D001224:Aspartic Acid / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors; D002540:Cerebral Cortex / Q000378:metabolism; D066298:In Vitro Techniques; D008024:Ligands; D008970:Molecular Weight; D016202:N-Methylaspartate; D010622:Phencyclidine / Q000031:analogs & derivatives* / Q000378:metabolism; D011719:Pyrazines / Q000378:metabolism*; D011869:Radioligand Assay; D051381:Rats; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter / Q000378:metabolism*
D008024:Ligands; D011719:Pyrazines; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter; D001224:Aspartic Acid; C014896:6-chloro-2-(1-piperazinyl)pyrazine; D016202:N-Methylaspartate; C012058:tenocyclidine; D010622:Phencyclidine